Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. Earnings Release 2016

Apr 18, 2016

7082_rns_2016-04-18_cff5033b-6c39-49b2-b113-a4f8524fc12e.htm

Earnings Release

Open in viewer

Opens in your device viewer

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD10817Corporation no: 520013954Stock Exchange/Market: NYSE310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] via MAGNA: 18/04/2016              Time of broadcast: 15:32 15:31:28

Reference: 2016-02-050941

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on ��� ����� �� ������ ������ ������ �� 2016 �- 9 ���� 2016
Q1_2016_Earnings_Announcement_-_ENG-HEB_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 03/04/2016
- - -
Name of the Signatory: : Beck Codner Iris , Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication , Name of Employer Company: .
Basel 5 Petach Tikva 49131 Telephone: 03-9267208 , Facsimile: 03-9267851 , E-mail: [email protected] 1